Pantoprazole Sodium NDC 72603-128

NDC codes

FDA NDC Directory

Product NDC (as listed)72603-128Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72603-0128Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72603-128-10	72603012810	10 VIAL, SINGLE-DOSE in 1 CARTON (72603-128-10) / 10 mL in 1 VIAL, SINGLE-DOSE (72603-128-01)Marketed from Aug 29, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pantoprazole Sodium
Generic name (nonproprietary): pantoprazole sodium
Active ingredients: Pantoprazole sodium — 40 mg/10mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Northstar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215860
Marketing start: Aug 29, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 72603-128_e74d873e-138b-4ba4-ba33-05a0998dc45dSPL ID e74d873e-138b-4ba4-ba33-05a0998dc45dSPL set ID 7e0c5dac-6832-4692-b012-ca59d5e88987RxCUI 283669UNII 6871619Q5XUPC 0372603128109
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472603012810 followed by a unit qualifier and the quantity

Package 72603-0128-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 8, 2026.

Indications (excerpt from the label)

Pantoprazole Sodium for Injection is indicated for treatment of: gastroesophageal reflux disease (GERD) and a history of erosive esophagitis (EE) for up to 10 days in adults. pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome in adults. Limitations of Use The safety and effectiveness of Pantoprazole Sodium for Injection for the treatment of upper gastrointestinal bleeding have not been established in adult or pediatric patients. Pediatric use information is approved for Pfizer Inc.'s PROTONIX® I.V. (pantoprazole sodium) for Injection. However, due to Pfizer Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. Pantoprazole …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215860

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215860
Product	Strength	Form · route	Labeler	Product NDC
Pantoprazole Sodium	Pantoprazole sodium 40 mg/10mL	Injection, Powder, For solutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-600
Pantoprazole Sodium	Pantoprazole sodium 40 mg/10mL	Injection, Powder, For solutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-600